Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials | Nature Communications
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials | Nature Communications,Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials | Nature Communications,Versatile magnetic hydrogel soft capsule microrobots for targeted delivery: iScience,Enhanced simulated early 21st century Arctic sea ice loss due to CMIP6 biomass burning emissions | Science Advances,Child Nutrition Trends Over the Past Two Decades and Challenges for Achieving Nutrition SDGs and National Targets in China